We have located links that may give you full text access.
Fat containing HCC: findings on CT and MRI including serial contrast-enhanced imaging.
Academic Radiology 2009 August
RATIONALE AND OBJECTIVES: The purpose of this article is to review the spectrum of computed tomography (CT) and magnetic resonance imaging (MRI) findings of fat containing hepatocellular carcinoma (HCC), including serial contrast-enhanced imaging.
MATERIALS AND METHODS: Imaging findings of 10 fat-containing HCCs on CT (n = 2) or MRI (n = 3) or on both CT and MRI (n = 5) were retrospectively reviewed in 9 patients. Both techniques included serial contrast enhanced imaging in arterial, portal venous, and late venous phases.
RESULTS: On non-contrast CT, fat containing HCC was either homogeneously hypodense (n = 6) or of mixed density (n = 1). The density values ranged between -11 and 9 HU. On MRI, homogenous (n = 4) or heterogeneous (n = 4) signal loss was observed on T1-weighted out-of-phase images as compared to in-phase images. Enhancement patterns on serial contrast-enhanced CT and MRI included: arterial enhancement indistinguishable from the liver with venous wash out (n = 2), arterial capillary blush with venous phase fading (n = 2), and heterogeneous arterial enhancement with unenhanced foci and venous phase wash out of enhancements. Larger lesions had late capsular enhancement.
CONCLUSIONS: Fat containing HCC has spectrum of imaging findings on CT and MRI. MRI with chemical shift technique depicts the fat content. Arterial contrast enhancement with venous washout or fading may help for the diagnosis of HCC in inconclusive cases.
MATERIALS AND METHODS: Imaging findings of 10 fat-containing HCCs on CT (n = 2) or MRI (n = 3) or on both CT and MRI (n = 5) were retrospectively reviewed in 9 patients. Both techniques included serial contrast enhanced imaging in arterial, portal venous, and late venous phases.
RESULTS: On non-contrast CT, fat containing HCC was either homogeneously hypodense (n = 6) or of mixed density (n = 1). The density values ranged between -11 and 9 HU. On MRI, homogenous (n = 4) or heterogeneous (n = 4) signal loss was observed on T1-weighted out-of-phase images as compared to in-phase images. Enhancement patterns on serial contrast-enhanced CT and MRI included: arterial enhancement indistinguishable from the liver with venous wash out (n = 2), arterial capillary blush with venous phase fading (n = 2), and heterogeneous arterial enhancement with unenhanced foci and venous phase wash out of enhancements. Larger lesions had late capsular enhancement.
CONCLUSIONS: Fat containing HCC has spectrum of imaging findings on CT and MRI. MRI with chemical shift technique depicts the fat content. Arterial contrast enhancement with venous washout or fading may help for the diagnosis of HCC in inconclusive cases.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app